AGL 38.10 Decreased By ▼ -1.48 (-3.74%)
AIRLINK 128.49 Decreased By ▼ -2.73 (-2.08%)
BOP 6.87 Increased By ▲ 0.06 (0.88%)
CNERGY 4.53 Decreased By ▼ -0.18 (-3.82%)
DCL 8.07 Decreased By ▼ -0.37 (-4.38%)
DFML 39.50 Decreased By ▼ -1.97 (-4.75%)
DGKC 78.47 Decreased By ▼ -3.62 (-4.41%)
FCCL 31.40 Decreased By ▼ -1.70 (-5.14%)
FFBL 70.20 Decreased By ▼ -2.67 (-3.66%)
FFL 11.99 Decreased By ▼ -0.27 (-2.2%)
HUBC 107.30 Decreased By ▼ -3.44 (-3.11%)
HUMNL 13.55 Decreased By ▼ -0.96 (-6.62%)
KEL 4.85 Decreased By ▼ -0.34 (-6.55%)
KOSM 7.50 Decreased By ▼ -0.11 (-1.45%)
MLCF 37.31 Decreased By ▼ -1.59 (-4.09%)
NBP 67.47 Increased By ▲ 3.46 (5.41%)
OGDC 187.60 Decreased By ▼ -5.22 (-2.71%)
PAEL 24.95 Decreased By ▼ -0.73 (-2.84%)
PIBTL 7.25 Decreased By ▼ -0.09 (-1.23%)
PPL 147.21 Decreased By ▼ -6.86 (-4.45%)
PRL 24.78 Decreased By ▼ -1.05 (-4.07%)
PTC 16.71 Decreased By ▼ -1.10 (-6.18%)
SEARL 79.40 Decreased By ▼ -2.90 (-3.52%)
TELE 7.35 Decreased By ▼ -0.41 (-5.28%)
TOMCL 32.35 Decreased By ▼ -1.11 (-3.32%)
TPLP 8.18 Decreased By ▼ -0.31 (-3.65%)
TREET 16.65 Increased By ▲ 0.03 (0.18%)
TRG 56.12 Decreased By ▼ -1.28 (-2.23%)
UNITY 27.65 Increased By ▲ 0.14 (0.51%)
WTL 1.32 Decreased By ▼ -0.05 (-3.65%)
BR100 10,239 Decreased By -265.6 (-2.53%)
BR30 30,232 Decreased By -994 (-3.18%)
KSE100 96,131 Decreased By -1949.1 (-1.99%)
KSE30 29,968 Decreased By -590.5 (-1.93%)

The Ministry of Health has nominated Ilyas Nainitalwala as member of the sub-committee for tariff rationalisation of pharmaceutical sector for the budget 2004-05.
The Experts Advisory Cells of Ministry of Industries and Production has constituted a sub-committee for tariff rationalisation of pharmaceutical sector for budget 2004-05.
The Director General Health is the convenor of the sub-committee. The objective of this exercise is to formulate practical and desirable proposals to address all aspects of federal taxation ie customs duties, central excise duty, sales tax and income tax in co-ordination with CBR, with the objective of making the local industry competitive both in the domestic and international markets, and discouraging the tendency of seeking tax and tariff preferences instead of finding solutions in productivity enhancement, validation and quality improvement.
The committee will also play an important role in finding solution for other cost elements such as energy cost etc.
Ilyas is already Senior vice chairman of FPCCI standing committee on pharmaceuticals.

Copyright Business Recorder, 2004

Comments

Comments are closed.